Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 14 min ago
Peer-reviewedCC BY-NC-ND 4.0Communications Medicine

Current translational perspectives for diagnosis and individualized therapy in rare genetic diseases

  • Sarfaraz K. Niazi
Open at sourcePDFDOICite

Related

  1. Bee-Derived Products in Neurodegenerative Diseases: Bioactive Constituents, Redox-Modulating Mechanisms, Evidence, and Translational Perspectives
    Jakub Garbarek, Oskar Hys, Alina Woźniak +2
    Molecules (Basel, Switzerland)Peer-reviewedCC BYFull textZoology & animal behaviourEurope PMCCrossref
  2. GLP-1 Receptor Agonists in Chronic Inflammatory Skin Diseases: Immunometabolic Mechanisms and Translational Perspectives
    Klara Andrzejczak, Emilia Kucharczyk, Matylda Korgiel +3
    PharmaceuticsPeer-reviewedCC BY5 citedImmunologyOpenAlex
  3. Trichoderma as a biological control agent against Colletotrichum -associated plant diseases: current insights and future perspectives
    Rendra Adhitya, Mia Miranti, Thomas Argyarich Jefferson +8
    Plant Signaling & BehaviorPeer-reviewedCC BY6 citedCell biologyPlant biologyOpenAlex
  4. The hormone–microbiota–NET framework in gynecologic diseases: evidence, controversies, and translational opportunities
    Huimin Xu, Tan Jiang, Muxi Li +1
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  5. HMGB1 functional plasticity in neurodegenerative diseases and its translational implications
    Weicai Cai, Yaqiao Yi, Rong Zeng +5
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{niazi2026current,
  title = {{Current translational perspectives for diagnosis and individualized therapy in rare genetic diseases}},
  author = {Sarfaraz K. Niazi},
  journal = {Communications Medicine},
  year = {2026},
  month = oct,
  doi = {10.1038/s43856-026-01962-3},
  url = {https://www.nature.com/articles/s43856-026-01962-3},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Current translational perspectives for diagnosis and individualized therapy in rare genetic diseases
AU  - Sarfaraz K. Niazi
PY  - 2026
DA  - 2026/10/02
JO  - Communications Medicine
DO  - 10.1038/s43856-026-01962-3
UR  - https://www.nature.com/articles/s43856-026-01962-3
SN  - 2730-664X
ER  -